Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients

Lung Cancer

Volumn 69, Issue 3, 2010, Pages 348-354

  Chen, Xi ^a   Wan, Jin ^b   Liu, Jiankun ^a   Xie, Wei ^a   Diao, Xinwei ^c   Xu, Jianping ^c   Zhu, Bo ^a   Chen, Zhengtang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

^c Xinqiao Hospital   (China)

Author keywords

IL 17; Lymphangiogenesis; Non small cell lung carcinoma; Th17

Indexed keywords

INTERLEUKIN 17;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SMOKING;

EID: 77955095712     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.11.013     Document Type: Article

References (42)

1. Machtay M., Jeremic B. Complex and controversial issues in locally advanced non-small cell lung carcinoma. Semin Surg Oncol 2003, 21:128-137.
2. Brundage M.D., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 2002, 122:1037-1057.
3. Renyi-Vamos F., Tovari J., Fillinger J., Timar J., Paku S., Kenessey I., et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer. Clin Cancer Res 2005, 11:7344-7353.
4. Cao Y., Zhong W. Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother 2007, 61:534-539.
5. Achen M.G., Stacker S.A. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 2006, 119:1755-1760.
6. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007, 109:1010-1017.
7. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995, 3:811-821.
8. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
9. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
10. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
11. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008, 8:337-348.
12. Sfanos K.S., Bruno T.C., Maris C.H., Xu L., Thoburn C.J., DeMarzo A.M., et al. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 2008, 14:3254-3261.
13. Steiner G.E., Newman M.E., Paikl D., Stix U., Memaran-Dagda N., Lee C., et al. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 2003, 56:171-182.
14. Le Gouvello S., Bastuji-Garin S., Aloulou N., Mansour H., Chaumette M.T., Berrehar F., et al. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008, 57:772-779.
15. Zhang J.P., Yan J., Xu J., Pang X.H., Chen M.S., Li L., et al. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 2009, 50:980-989.
16. Zhu X., Mulcahy L.A., Mohammed R.A., Lee A.H., Franks H.A., Kilpatrick L., et al. IL-17 expression by breast-cancer-associated macrophages. IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 2008, 10:R95.
17. Miyahara Y., Odunsi K., Chen W., Peng G., Matsuzaki J., Wang R.F. Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA 2008, 105:15505-15510.
18. Numasaki M., Watanabe M., Suzuki T., Takahashi H., Nakamura A., McAllister F., et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol 2005, 175:6177-6189.
19. Kato T., Furumoto H., Ogura T., Onishi Y., Irahara M., Yamano S., et al. Expression of IL-17 mRNA in ovarian cancer. Biochem Biophys Res Commun 2001, 282:735-738.
20. Hirahara N., Nio Y., Sasaki S., Minari Y., Takamura M., Iguchi C., et al. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice. Oncology 2001, 61:79-89.
21. Hirahara N., Nio Y., Sasaki S., Takamura M., Iguchi C., Dong M., et al. Reduced invasiveness and metastasis of Chinese hamster ovary cells transfected with human interleukin-17 gene. Anticancer Res 2000, 20:3137-3142.
22. Benchetrit F., Ciree A., Vives V., Warnier G., Gey A., Sautes-Fridman C., et al. Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 2002, 99:2114-2121.
23. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., et al. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65-70.
24. Weidner N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin Diagn Pathol 1993, 10:302-313.
25. Chen F., Takenaka K., Ogawa E., Yanagihara K., Otake Y., Wada H., et al. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer. Clin Cancer Res 2004, 10:8548-8553.
26. Numasaki M., Fukushi J., Ono M., Narula S.K., Zavodny P.J., Kudo T., et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003, 101:2620-2627.
27. Prud'homme G.J. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 2007, 87:1077-1091.
28. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007, 8:1390-1397.
29. Stritesky G.L., Yeh N., Kaplan M.H. IL-23 promotes maintenance but not commitment to the Th17 lineage. J Immunol 2008, 181:5948-5955.
30. Langowski J.L., Kastelein R.A., Oft M. Swords into plowshares: IL-23 repurposes tumor immune surveillance. Trends Immunol 2007, 28:207-212.
31. Houghton A.M., Mouded M., Shapiro S.D. Common origins of lung cancer and COPD. Nat Med 2008, 14:1023-1024.
32. Turner M.C., Chen Y., Krewski D., Calle E.E., Thun M.J. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007, 176:285-290.
33. Hinrichs C.S., Kaiser A., Paulos C.M., Cassard L., Sanchez-Perez L., Heemskerk B., et al. Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 2009, 114:596-599.
34. Kryczek I., Wei S., Szeliga W., Vatan L., Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009, 114:357-359.
35. Kryczek I., Banerjee M., Cheng P., Vatan L., Szeliga W., Wei S., et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009, 114:1141-1149.
36. Mantovani A. Cancer: inflaming metastasis. Nature 2009, 457:36-37.
37. Tartour E., Fossiez F., Joyeux I., Galinha A., Gey A., Claret E., et al. Sautes-Fridman C. Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999, 59:3698-3704.
38. Gaffen S.L. An overview of IL-17 function and signaling. Cytokine 2008, 43:402-407.
39. Watari K., Nakao S., Fotovati A., Basaki Y., Hosoi F., Bereczky B., et al. Role of macrophages in inflammatory lymphangiogenesis: enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem Biophys Res Commun 2008, 377:826-831.
40. Cha H.S., Bae E.K., Koh J.H., Chai J.Y., Jeon C.H., Ahn K.S., et al. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes. J Rheumatol 2007, 34:16-19.
41. Sun J.G., Wang Y., Chen Z.T., Zhuo W.L., Zhu B., Liao R.X., et al. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value. J Exp Clin Cancer Res 2009, 28:21.
42. Kawai H., Minamiya Y., Ito M., Saito H., Ogawa J. VEGF121 promotes lymphangiogenesis in the sentinel lymph nodes of non-small cell lung carcinoma patients. Lung Cancer 2008, 59(1):41-47.